HW&C
HC Wainwright & Co. Latest Price Targets & Analyst Ratings
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Communication Services
Consumer Discretionary
Consumer Staples
Energy
Financials
Healthcare
Industrials
Materials
Real Estate
Technology
Utilities
Communication Services
Advertising Agencies
Broadcasting
Electronic Gaming & Multimedia
Entertainment
Internet Content & Information
Publishing
Telecom Services
Consumer Discretionary
Apparel Manufacturing
Apparel Retail
Auto Manufacturers
Auto Parts
Auto & Truck Dealerships
Department Stores
Footwear & Accessories
Furnishings, Fixtures & Appliances
Gambling
Home Improvement Retail
Internet Retail
Leisure
Lodging
Luxury Goods
Packaging & Containers
Personal Services
Recreational Vehicles
Residential Construction
Resorts & Casinos
Restaurants
Specialty Retail
Textile Manufacturing
Travel Services
Consumer Staples
Beverages - Brewers
Beverages - Non-Alcoholic
Beverages - Wineries & Distilleries
Confectioners
Discount Stores
Education & Training Services
Farm Products
Food Distribution
Grocery Stores
Household & Personal Products
Packaged Foods
Tobacco
Energy
Oil & Gas Drilling
Oil & Gas Equipment & Services
Oil & Gas Exploration & Production
Oil & Gas Integrated
Oil & Gas Midstream
Oil & Gas Refining & Marketing
Thermal Coal
Uranium
Financials
Asset Management
Banks - Diversified
Banks - Regional
Capital Markets
Credit Services
Diversified Insurance
Financial Conglomerates
Financial Data & Stock Exchanges
Insurance Brokers
Life Insurance
Mortgage Finance
Property & Casualty Insurance
Reinsurance
Shell Companies
Specialty - Insurance
Healthcare
Biotechnology
Diagnostics & Research
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Healthcare Plans
Health Information Services
Medical Care Facilities
Medical Devices
Medical Distribution
Medical Instruments & Supplies
Pharmaceutical Retailers
Industrials
Aerospace & Defense
Airlines
Airports & Air Services
Building Products & Equipment
Business Equipment & Supplies
Conglomerates
Consulting Services
Electrical Equipment & Parts
Engineering & Construction
Farm & Heavy Construction Machinery
Industrial Distribution
Infrastructure Operations
Integrated Freight & Logistics
Marine Shipping
Metal Fabrication
Pollution & Treatment Controls
Railroads
Rental & Leasing Services
Security & Protection Services
Specialty Business Services
Specialty Industrial Machinery
Staffing & Employment Services
Tools & Accessories
Trucking
Waste Management
Materials
Agricultural Inputs
Aluminum
Building Materials
Chemicals
Coking Coal
Copper
Gold
Lumber & Wood Production
Other Industrial Metals & Mining
Other Precious Metals & Mining
Paper & Paper Products
Silver
Specialty Chemicals
Steel
Real Estate
Diversified REIT
Healthcare Facilities REIT
Hotel & Motel REIT
Industrial REIT
Mortgage REIT
Office REIT
Real Estate Development
Real Estate Diversified
Real Estate Services
Residential REIT
Retail REIT
Specialty REIT
Technology
Communication Equipment
Computer Hardware
Consumer Electronics
Electronic Components
Electronics & Computer Distribution
Information Technology Services
Scientific & Technical Instruments
Semiconductor Equipment & Materials
Semiconductors
Software - Application
Software - Infrastructure
Solar
Utilities
Diversified Utilities
Electric Utilities
Gas Utilities
Independent Power Producers
Renewable Electricity
Water Utilities
Positive
Neutral
Negative
7 Days
1 Month
3 Months
6 Months
# | Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|---|
626 |
626
Cingulate
CING
$20.8M
|
RS
Raghuram Selvaraju
| $3.84 | $20 |
421%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
627 |
627
Kamada
KMDA
$411M
|
AF
Andrew Fein
| $7.14 | $11 |
54%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
628 |
628
Protara Therapeutics
TARA
$120M
|
AF
Andrew Fein
| $3.11 | $23 |
640%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
629 |
629
TScan Therapeutics
TCRX
$104M
|
AF
Andrew Fein
| $1.84 | $15 |
715%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
630 |
630
Fuel Tech
FTEK
$98.8M
|
AD
Amit Dayal
| $3.18 | $4 |
26%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
631 |
631
Alto Ingredients
ALTO
$89M
|
AD
Amit Dayal
| $1.15 | $5.50 |
378%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
632 |
632
Broadwind
BWEN
$50M
|
AD
Amit Dayal
| $2.17 | $6 |
177%
upside
| Buy |
6 Mar ‘25
6 months ago |
|
633 |
633
Senseonics Holdings
SENS
$357M
|
VB
Vernon Bernardino
| $0.4384 | $2 |
356%
upside
| Buy |
5 Mar ‘25
6 months ago |
|
634 |
634
Rigel Pharmaceuticals
RIGL
$654M
|
JP
Joseph Pantginis
| $36.48 | $57 |
56%
upside
| Buy |
5 Mar ‘25
6 months ago |
|
635 |
635
Artelo Biosciences
ARTL
$6.38M
|
VB
Vernon Bernardino
| $4.83 | $30 |
521%
upside
| Buy |
4 Mar ‘25
6 months ago |
|
636 |
AVDL
636
Avadel Pharmaceuticals
AVDL
$1.54B
|
OL
Oren Livnat
| $15.81 | $21 |
33%
upside
| Buy |
4 Mar ‘25
6 months ago |
|
637 |
637
TG Therapeutics
TGTX
$5.05B
|
EW
Edward White
| $31.82 | $55 |
73%
upside
| Buy |
4 Mar ‘25
6 months ago |
|
638 |
638
Syndax Pharmaceuticals
SNDX
$1.36B
|
EW
Edward White
| $15.73 | $51 |
224%
upside
| Buy |
4 Mar ‘25
6 months ago |
|
639 |
639
4D Molecular Therapeutics
FDMT
$324M
|
MC
Matthew Caufield
| $6.94 | $36 |
419%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
640 |
640
Merus
MRUS
$5.08B
|
AF
Andrew Fein
| $67.13 | $85 |
27%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
641 |
641
Akero Therapeutics
AKRO
$3.46B
|
EA
Ed Arce
| $43.25 | $75 |
73%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
642 |
642
Apellis Pharmaceuticals
APLS
$3.29B
|
DT
Douglas Tsao
| $26.04 | $57 |
119%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
643 |
643
Janux Therapeutics
JANX
$1.46B
|
SR
Swayampakula Ramakanth
| $24.31 | $70 |
188%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
644 |
644
Calumet Specialty Products
CLMT
$1.53B
|
AD
Amit Dayal
| $17.66 | $33 |
87%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
645 |
645
89bio
ETNB
$1.26B
|
EA
Ed Arce
| $8.52 | $21 |
146%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
646 |
646
Vir Biotechnology
VIR
$713M
|
PT
Patrick Trucchio
| $5.13 | $110 |
2,044%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
647 |
647
Catalyst Pharmaceutical
CPRX
$2.42B
|
AF
Andrew Fein
| $19.74 | $35 |
77%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
648 |
648
Mirum Pharmaceuticals
MIRM
$3.76B
|
EA
Ed Arce
| $74.89 | $72 |
4%
downside
| Buy |
28 Feb ‘25
6 months ago |
|
649 |
649
Vericel Corp
VCEL
$1.58B
|
SR
Swayampakula Ramakanth
| $31.31 | $60 |
92%
upside
| Buy |
28 Feb ‘25
6 months ago |
|
650 |
650
Puma Biotechnology
PBYI
$229M
|
EW
Edward White
| $4.54 | $7 |
54%
upside
| Buy |
28 Feb ‘25
6 months ago |
|